Search

Your search keyword '"Jiménez-Fonseca P"' showing total 359 results

Search Constraints

Start Over You searched for: Author "Jiménez-Fonseca P" Remove constraint Author: "Jiménez-Fonseca P"
359 results on '"Jiménez-Fonseca P"'

Search Results

2. Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?

3. Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancer

4. CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer

6. Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials

9. Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry

16. Influencia de la dignidad percibida y estrategias de afrontamiento en la incertidumbre y malestar emocional de pacientes con cáncer avanzado.

24. On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism

25. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU

26. Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry

29. The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism

32. Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer

34. Performance of the clinical index of stable febrile neutropenia (CISNE) in different types of infections and tumors

35. Estudio psicométrico de las pruebas MIR de 2020 y 2021

40. Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study

44. 1935P Sequence matters: Impact of first-line response in overall therapeutic outcome in differentiated thyroid cancer. Data from the Spanish national registry of thyroid cancer (REGETNE-Tiroides)

45. 1936P Treatment outcomes of patients with anaplastic thyroid carcinoma (atc): Multicentric data from spanish national registry (regetne-tiroides)

46. 1856P Prediction of clinically significant bleeding in anticoagulated patients for cancer-associated venous thromboembolism: Validation of B-CAT score in a cohort from the TESEO study

47. 1157P Retreatment with peptide receptor radionuclide therapy (PRRT) in patients (p) with neuroendocrine tumors (NET): Spanish clinical experience from SEPTRALU national registry

48. 1144O Osteopontin (OPN) predicts the efficacy of anti-angiogenic therapy with multikinase inhibitors (MKIs) in advanced neuroendocrine tumors (NETs): Underlying molecular mechanisms

50. 1142O Multivariable analysis of streptozotocin plus 5-fluorouracil and everolimus sequences in advanced pancreatic neuroendocrine tumor patients: The SEQTOR trial (GETNE-1206)

Catalog

Books, media, physical & digital resources